Moteur de recherche d’entreprises européennes
Financement de l’UE (2 998 313 €) : Prevention and Screening Innovation Project Towards Elimination of Cervical Cancer Hor01/02/2021 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Prevention and Screening Innovation Project Towards Elimination of Cervical Cancer
The proposed Prevention and Screening Innovation Project towards Elimination of Cervical Cancer (PRESCRIP-TEC) will lead to effective and innovative cervical cancer screening, including direct treatment and follow-up for women in resource-poor or hard-to-reach settings in the world, by improving availability, accessibility, acceptability and quality of services. PRESCRIP-TEC will conduct implementation research into cervical cancer screening and secondary prevention in different settings in four countries over three continents: Bangladesh and India in Asia, Uganda in Africa, and Slovakia in Eastern Europe. We will analyse patient- and health services-related facilitators and barriers for uptake of cervical cancer screening in low- and middle-income countries and in vulnerable groups in Eastern Europe. By taking existing screening protocols in the four countries, we will introduce 1) interactive information with communities via mobile devices and social media; 2) client-friendly, community-based strategies, with self-test for high risk HPV infection; and 3) artificial intelligence in gynaecological examination. The use of artificial intelligence built into mobile devices offers a future for high quality diagnostics in resource-poor settings. By doing so, we will reduce the number of physical examinations and implement screenings by lower-level trained cadres. In addition, through a cost-effectiveness analysis and a business case for the global introduction of hrHPV testing as routine screening for cervical cancer, we will show the advantage of point-of-delivery testing and the benefits of self-testing for cancer in the post-COVID era, which reduces pressure on the health system. PRESCRIP-TEC will strengthen evidence of innovative strategies for cervical cancer screening as advocated by the World Health Organization and will contribute to eradication of cervical cancer worldwide through prevention and early diagnosis, alleviating the global burden of cancer.
| ACADEMISCH ZIEKENHUIS GRONINGEN | 569 000 € |
| ACADEMISCH ZIEKENHUIS LEIDEN | 0,00 € |
| CBCI Society for Medical Education | 0,00 € |
| Chittaranjan National Cancer Institute | 0,00 € |
| Connaxis Servicios de Marketing SL | 222 500 € |
| FEMALE CANCER Foundation | 656 750 € |
| Friendship | 239 375 € |
| International Centre FOR Diarrhoeal Disease Research Bangladesh | 135 750 € |
| Liga Proti Rakovine Slovenskej Republiky | 29 000 € |
| Manipal Academy OF Higher Education | 0,00 € |
| Shri Dharmasthala Manjunatheshwaraeducational Society, Ujire | 0,00 € |
| Sikkim Manipal University | 0,00 € |
| Tata Medical Centre Trust | 0,00 € |
| Tata Memorial Centre Society | 0,00 € |
| The University of Edinburgh | 47 500 € |
| Trnavska Univerzita V Trnave | 703 750 € |
| Uganda Cancer Institute | 79 000 € |
| Uganda Rural Development AND Training Programme | 243 438 € |
| Zdrave Regiony | 72 250 € |
https://cordis.europa.eu/project/id/964270
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.
Les visualisations de "ACADEMISCH ZIEKENHUIS GRONINGEN - Financement de l’UE (2 998 313 €) : Prevention and Screening Innovation Project Towards Elimination of Cervical Cancer"
sont mis à disposition par
North Data
et peuvent être réutilisées selon les termes de la licence
Creative Commons CC-BY.
